The firm’s new report* predicts Denmark’s pharmaceuticals sector to grow from US$4 billion in 2011 to US$7.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 6.9%. This expected growth follows three years of shrinking pharmaceutical revenue for the north European country.
Additionally, Denmark’s medical devices sector is forecast to grow from 2011’s total of US$1.4 billion, to US$2.3 billion by the end of the decade.
GlobalData attributes Denmark’s healthcare industry expansion to a growing elderly population: 16.8% of Danish citizens were 65 years old or older in 2011, with this proportion reaching 19.6% by 2020, according to Statistics Denmark.
Additionally, Denmark’s pharmaceutical market will be bolstered by investment in innovative products. Novo Nordisk, along with other Danish firms such as LEO Pharma and Lundbeck, invest 15%–20% of their revenues in R&D. Furthermore, the country’s biotechnology sector spent approximately US$5.2 billion on R&D in 2011 – the second highest in Europe.
For Sample Pages, please click or add the below link to your browser:
However, Denmark is not lacking in obstacles to overcome. At 25%, Value Added Tax (VAT) in the country is higher than that of other countries in the EU (UK and the
Netherlands have 20% and 19% respectively)
all other nations in the Organization for Economic Co-operation and Development (OECD), with the exception of Norway. Consequently, manufacturing and sales costs are substantial in Denmark.
This report is an essential source of information and analysis on Denmark`s healthcare, regulatory and reimbursement landscape.
This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.
GlobalData is a leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.
For further details, please click or add the below link to your browser:
Visit our report store:
For more details contact:pressreleases@
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782